Anthony Michael Jevnikar

Professor of Medicine

London Health Sciences Centre

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anthony Michael Jevnikar is a Professor of Medicine at the London Health Sciences Centre in Canada. His research focuses on transplant immunology, with recent articles examining topics such as noninvasive monitoring of renal transplants, the effects of cytomegalovirus infections on allograft outcomes, and the clinical significance of various complications in transplantation. Dr. Jevnikar's work aims to enhance patient care and outcomes in the field of organ transplantation.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Zhu-Xu Zhang

professor

Western University

CANADA

View details

Banu Sis

University of Alberta Hospital

CANADA

View details

Eric Weimer

UNITED STATES

View details

Seyed M Hosseini-Moghaddam

university health network and university of toronto

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anthony Michael Jevnikar

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The effect of late-onset CMV infection on the outcome of renal allograft considering initial graft function

Multicenter Validation of a Urine CXCL10 Assay for Noninvasive Monitoring of Renal Transplants

Hepatitis C positive organ transplantation to negative recipients at a multiorgan Canadian transplant centre: ready for prime time

High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation.

Six‐month risk of Pneumocystis pneumonia following acute cellular rejection: A case‐control study in solid organ transplant recipients

Late‐onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti‐CMV prophylaxis required following late‐onset allograft rejection?

Toll-like receptor 3 is an endogenous sensor of cell death and a potential target for induction of long-term cardiac transplant survival

Clinical Significance of Isolated V1 Arteritis in Renal Transplantation

Long‐lasting cluster of nosocomial pneumonia with a single Pneumocystis jirovecii genotype involving different organ allograft recipients

Projecting the Number of Posttransplant Clinic Visits With a Rise in the Number of Kidney Transplants: A Case Study From Ontario, Canada

Collaborators (4)

Zhu-Xu Zhang

Banu Sis

Eric Weimer

Seyed M Hosseini-Moghaddam

Make your next move.